BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37895312)

  • 21. Circular RNA hsa_circ_0051040 Promotes Hepatocellular Carcinoma Progression by Sponging miR-569 and Regulating ITGAV Expression.
    Ju L; Yao M; Lu R; Cao Y; Wang H; Yuan L; Xiao F; Shao J; Cai W; Chen L; Bian Z
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum hsa_circ_0000615 is a prognostic biomarker of sorafenib resistance in hepatocellular carcinoma.
    Zhang L; Xu T; Li Y; Pang Q; Ding X
    J Clin Lab Anal; 2022 Nov; 36(11):e24741. PubMed ID: 36268976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. circCORO1C promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing the expression of PD-L1 through NF-κB pathway.
    Wu F; Sun G; Zheng W; Tang W; Cheng Y; Wu L; Li X; Tao J; Ma S; Cao H
    J Clin Lab Anal; 2021 Dec; 35(12):e24003. PubMed ID: 34676904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma.
    Wang S; Cui S; Zhao W; Qian Z; Liu H; Chen Y; Lv F; Ding HG
    Cancer Biomark; 2018; 22(4):631-640. PubMed ID: 29914004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
    Gong J; Du C; Sun N; Xiao X; Wu H
    J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
    Li X; Shen M
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(2):555-566. PubMed ID: 30720163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of hsa_circ_0001649 in hepatocellular carcinoma predicts a poor prognosis.
    Zhang X; Qiu S; Luo P; Zhou H; Jing W; Liang C; Tu J
    Cancer Biomark; 2018; 22(1):135-142. PubMed ID: 29630526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsa_circ_0003998 may be used as a new biomarker for the diagnosis and prognosis of hepatocellular carcinoma.
    Qiao GL; Chen L; Jiang WH; Yang C; Yang CM; Song LN; Chen Y; Yan HL; Ma LJ
    Onco Targets Ther; 2019; 12():5849-5860. PubMed ID: 31410028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNA hsa_circ_0005239 contributes to hepatocellular carcinoma cell migration, invasion, and angiogenesis by targeting the miR-34a-5p/PD-L1 axis.
    He T; Huang J; Liang H; Zhong B; Xu G; Zhu X
    Cell Biol Int; 2023 Sep; 47(9):1519-1534. PubMed ID: 37208963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulated circ_0004913, circ_0008160, circ_0000517, and their potential as biomarkers for disease monitoring and prognosis in hepatocellular carcinoma.
    Li X; Yang J; Yang X; Cao T
    J Clin Lab Anal; 2021 Jun; 35(6):e23785. PubMed ID: 34018640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hsa_circ_0007456 regulates the natural killer cell-mediated cytotoxicity toward hepatocellular carcinoma via the miR-6852-3p/ICAM-1 axis.
    Shi M; Li ZY; Zhang LM; Wu XY; Xiang SH; Wang YG; Zhang YQ
    Cell Death Dis; 2021 Jan; 12(1):94. PubMed ID: 33462208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circular RNA hsa_circ_0016788 regulates hepatocellular carcinoma tumorigenesis through miR-486/CDK4 pathway.
    Guan Z; Tan J; Gao W; Li X; Yang Y; Li X; Li Y; Wang Q
    J Cell Physiol; 2018 Jan; 234(1):500-508. PubMed ID: 29923236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.
    Liu G; Guo W; Rao M; Qin J; Hu F; Li K
    Cell Transplant; 2020; 29():963689720963948. PubMed ID: 33028110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma.
    Fu L; Chen Q; Yao T; Li T; Ying S; Hu Y; Guo J
    Oncotarget; 2017 Jul; 8(27):43878-43888. PubMed ID: 28410211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circular RNA hsa_circ_0078602 may have potential as a prognostic biomarker for patients with hepatocellular carcinoma.
    Kou P; Zhang C; Lin J; Wang H
    Oncol Lett; 2019 Feb; 17(2):2091-2098. PubMed ID: 30675276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma circular RNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma: A large-scale, multicenter study.
    Yu J; Ding WB; Wang MC; Guo XG; Xu J; Xu QG; Yang Y; Sun SH; Liu JF; Qin LX; Liu H; Yang F; Zhou WP
    Int J Cancer; 2020 Mar; 146(6):1754-1763. PubMed ID: 31456215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Potential of Serum Exosomal hsa_circ_0028861 as the Novel Diagnostic Biomarker of HBV-Derived Hepatocellular Cancer.
    Wang Y; Pei L; Yue Z; Jia M; Wang H; Cao LL
    Front Genet; 2021; 12():703205. PubMed ID: 34367259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARα/CCL2 pathway.
    Wang X; Sheng W; Xu T; Xu J; Gao R; Zhang Z
    Aging (Albany NY); 2021 Apr; 13(8):11969-11987. PubMed ID: 33891564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel potential tumor biomarkers: Circular RNAs and exosomal circular RNAs in gastrointestinal malignancies.
    Wang Y; Li Z; Xu S; Guo J
    J Clin Lab Anal; 2020 Jul; 34(7):e23359. PubMed ID: 32419229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Circular RNA hsa_circ_0001445 Regulates the Proliferation and Migration of Hepatocellular Carcinoma and May Serve as a Diagnostic Biomarker.
    Zhang X; Zhou H; Jing W; Luo P; Qiu S; Liu X; Zhu M; Liang C; Yu M; Tu J
    Dis Markers; 2018; 2018():3073467. PubMed ID: 29785229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.